| Cash Flow | 2025-09-30 |
|---|---|
| Net loss | -2,387 |
| Depreciation | 1 |
| Stock-based compensation | 1,679 |
| Gain on deconsolidation of subsidiary | 4,947 |
| Accounts receivable, net | 725 |
| Inventory | 1,368 |
| Prepaid expenses and other assets | -1,855 |
| Lease liability | 5 |
| Accounts payable, accrued and other current liabilities | -8,744 |
| Net cash used in operating activities | -4,737 |
| Proceeds, net of issuance costs, from issuing common stock and pre-funded warrants, net | 5,564 |
| Payment of preferred stock dividend | 41 |
| Net cash provided by financing activities | 5,523 |
| Effect of exchange rate changes on cash and cash equivalents | -85 |
| Net increase (decrease) in cash and cash equivalents | 701 |
| Cash and cash equivalents at beginning of period | 3,137 |
| Cash and cash equivalents at end of period | 3,838 |
Bio Green Med Solution, Inc. (BGMS)
Bio Green Med Solution, Inc. (BGMS)